Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of NGL Fine-Chem Limited
No Price
Closing Price XNSE 29.04.2026:
2.281,80 INR
29.04.2026 10:00
Current Prices from NGL Fine-Chem Limited
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
NSE
NGLFINE.NS
INR
29.04.2026 10:00
2.281,80 INR
21,60 INR
+0,96 %
MSE
NGLFINE.BO
INR
29.04.2026 09:37
2.268,95 INR
8,75 INR
+0,39 %
Share Float & Liquidity
Free Float25,64 %
Shares Float1,58 M
Shares Outstanding6,18 M
Company Profile for NGL Fine-Chem Limited Share
NGL Fine-Chem Limited manufactures and sells pharmaceuticals and intermediates for use in veterinary and human health worldwide. It offers active pharmaceutical ingredients, such as diminazene aceturate, diminazene diaceturate, homidium chloride, nitroxynil, clorsulon, parvaquone, buparvaquone, isometamidium chloride hydrochloride, toldimfos sodium, butaphosphan, imidocarb dipropionate, triclabendazole, ractopamine HCl, S-methoprene, praziquantel, toltrazuril, decoquinate, flunixin meglumine, carprofen, fenbendazole, amitraz, xylazine hydrochloride, and marbofloxacin for animal health applications; and nitazoxanide and atovaquone for human health applications. The company provides various intermediate products and specialty chemicals; and finished dosage forms in granules and tablets. NGL Fine-Chem Limited was incorporated in 1981 and is based in Mumbai, India.
